Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-α2b/ribavirin or induction-dose interferon-α2b/ ribavirin/amantadine: A non-randomized controlled study
American Journal of Gastroenterology, Volume 100, No. 11, Year 2005